Eli Lilly’s run of near-weekly acquisitions still shows no sign of letting up, with the Big Pharma now buying Ajax ...

Eli Lilly and Company (NYSE:LLY) is among the 15 Best Big Name Stocks to Buy. On April 21, Barclays analyst Emily Field ...

Eli Lilly is best known for its work in the weight loss market. The company has billion-dollar drugs in other areas. The ...

By Christy Santhosh April 27 (Reuters) - Eli Lilly said on Monday it would buy privately held cancer drug developer Ajax ...

Lilly will buy Ajax, whose lead medicine is a once-daily pill in the early stages of study for a rare type of blood cancer.

Eli Lilly (LLY) acquires Ajax Therapeutics for $2.3B, adding AJ1-11095, a novel JAK2 inhibitor for myelofibrosis and blood ...

Eli Lilly (LLY) has agreed to acquire biopharmaceutical company Ajax Therapeutics for up to $2.3B in cash, inclusive of an ...

Eli Lilly is picking up its second in vivo CAR-T company of the year, paying $3.25 billion in upfront cash for Kelonia ...

Kelonia is developing technology to reprogram patients' T-cells inside the body so those cells can attack cancer, called in ...

Why Wall Street loves Lilly. So what does this Wall Street analyst like about Lilly? Yesterday, Eli Lilly announced it will ...

Indianapolis-based drug giant Eli Lilly and Co. on Monday announced an agreement to acquire cancer-drug developer Ajax ...

Eli Lilly and Rigel Pharmaceuticals partnered in February 2021 to advance a pair of RIPK1 blockers, but the pharma in October ...